A sweeping Cochrane review of 93 studies confirms that doctors who accept gifts, meals, and payments from pharmaceutical companies prescribe more medications — and less appropriate ones. The more industry contact a physician had, the worse their prescribing patterns. Experts say conflict-of-interest policies help, but a broader cultural and regulatory shift may be needed to truly break the cycle.
A new Cochrane review of 93 studies — drawing on prescribing data from millions of providers, mostly in the US — finds that physicians who accept gifts and payments from pharmaceutical companies write more prescriptions for promoted drugs, and those prescriptions tend to be less appropriate and more expensive. The strongest correlations came from gifts and payments, while the impact of free samples remained unclear. Industry-sponsored meals showed a striking "dose-response" effect: the more meals a doctor received, the more they prescribed the promoted drug.
What makes this tricky is that most doctors don't believe they're being influenced. Experts note it's a well-documented blind spot — physicians acknowledge that marketing sways their colleagues, but not themselves. The federal Open Payments database has helped researchers move beyond self-reporting, linking payment records directly to prescribing data and strengthening the evidence base.
By the Numbers
Why it matters: Conflict-of-interest policies at institutions probably improve prescribing appropriateness, but experts argue that systemic change — including stricter federal regulation — may be the only way to meaningfully separate industry influence from clinical decision-making.
